Richard Steinhart

Richard I.
Steinhart is an Independent Director at Atossa Therapeutics, Inc. since 2014, an Independent Director at Actinium Pharmaceuticals, Inc. since 2013, and the Chief Financial & Accounting Officer, Senior VP at BioXcel Therapeutics, Inc. since 2017.
He previously worked as an Independent Director at TG Therapeutics, Inc. from 2004 to 2012, a Managing Director at Forest Street Capital, LLC from 1992 to 2006, and a Managing Director at SAE Ventures.
He also served as the Chief Financial Officer & Vice President at Emisphere Technologies, Inc. from 1991 to 1992, the CFO, Secretary, Treasurer & Senior VP-Finance at STRATA Skin Sciences, Inc. from 2006 to 2013, and the Chief Financial Officer & General Partner at CW Group, Inc. from 1991 to 1992.
Additionally, he was the Chief Financial Officer & Vice President at Remedy Pharmaceuticals, Inc. from 2015 to 2017 and the Chief Financial Officer & SVP-Finance at MELA Sciences Inc. from 2012 to 2013.
Mr. Steinhart holds an undergraduate degree and an MBA from Pace University.